We’ve reinvented business process outsourcing.

See HowClose
Evolve Devices
Evolve

There was a time, when a phone was just a phone. Then almost overnight it became a camera, computer, flashlight, compass and entertainment center. Now, you rely on it for almost anything you need. Imagine if this were our industry. Imagine if all your outsourced services were under one roof. We did.

Learn More

DOHMEN NEWS

Learn what's happening in the world of Dohmen and our clients

NEWS

  • thumbnail_2
    Feb 20, 2017

    Dohmen releases new white paper on improved outsourcing model for orphan drug manufacturers

    The $114 billion orphan drug industry is traditionally served by a multi-channel model of disparate service providers. Each claims expertise in a specific niche of services, yet therapy adherence for rare disease patients is just over 58 percent. The Dohmen Life Science Services white paper explores an integrated outsourcing model that’s driving better adherence, supporting healthier outcomes and helping orphan drug manufacturers continuously improve their patient program with lower cost and less risk. Industry experts and patient advocates weigh in on why business process outsourcing must evolve.
    Full Story
  • BioForward Media Center Image
    Dec 20, 2016

    Dohmen leaders named to BioForward Board of Directors, poised to spark more innovation in Wisconsin

    Showcasing Dohmen’s commitment to growing the life sciences sector in Wisconsin, today BioForward, the state’s growing biohealth industry association, named Dohmen leaders to its Board of Directors. Eric Floyd, Chief Science Officer for Dohmen Life Science Services was appointed for the 2017-19 term.
    Full Story
  • Global Genes Logo 12.20.16
    Dec 20, 2016

    Dohmen’s Wendy White named Global Genes Chairman of the Board

    Global Genes, one of the world’s leading nonprofit rare disease patient advocacy organizations, recently named Wendy White, Dohmen Life Science Services (DLSS) Senior Vice President, Rare Disease, as the Chairman of the Board.
    Full Story

PRESS RELEASES